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Summary 
The CCAAT/Enhancer-binding protein β (C/EBPβ) was first identified as a regulator of 
differentiation and inflammatory processes in adipose tissue and liver. Although 
C/EBPβ was initially implicated in synaptic plasticity, its function in the brain remains 
largely unknown. We have previously shown that C/EBPβ regulates the expression of 
genes involved in inflammatory processes and brain injury. Here, we have demonstrated 
that the expression of C/EBPβ is notably increased in the hippocampus in a murine 
model of excitotoxicity. Mice lacking C/EBPβ showed a reduced inflammatory 
response after kainic acid injection and exhibited a dramatic reduction in pyramidal cell 
loss in the CA1 and CA3 subfields of the hippocampus. These data reveal an essential 
function for C/EBPβ in the pathways leading to excitotoxicity-mediated damage and 
suggest that inhibitors of this transcription factor should be evaluated as possible 
neuroprotective therapeutic agents. 
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Introduction 
Cell death resulting from excitotoxicity has been associated with different brain 
disorders (Coyle and Puttfarcken, 1993; Doble, 1999; Meldrum, 2000). In these 
diseases, accumulating evidence implicates an inflammatory response in affected 
regions. Glial cells, as mediators of the inflammatory response, also play an important 
role in the course of kainic acid (KA)-induced hippocampal neurodegeneration. 
Activated astrocytes and microglia cells proliferate and increase the expression of genes 
implicated in the production of nitric oxide and pro-inflammatory cytokines. These 
agents, when released from activated glia, can contribute noticeably to the expansion of 
brain injury and the increased loss of neurons (Oprica et al., 2003).  
 
Excitotoxicity can be triggered by the administration of KA, which results in behavioral 
changes and neuronal damage initiated by activation of KA-receptors in the CA3 region 
of the hippocampus (Krnjevic et al., 1980). This activation results in a depolarization of 
the cells, resulting in a significant increase in Ca2+ entry, which leads to neuronal death. 
Particularly sensitive are the hippocampal CA1 and CA3 regions, and the hilar neurons 
of the dentate gyrus (Coyle, 1983; Sperk et al., 1985). Injection of KA into rodents also 
results in the activation of glial cells and inflammatory responses typically found in 
neurodegenerative diseases. Hence, this model has been used extensively to analyze the 
cellular and molecular mechanisms that underlie central nervous system damage. 
 
The CCAAT/Enhancer binding protein β (C/EBPβ) is a member of the transcriptional 
factor family consisting of six functionally and structurally related basic leucine zipper 
DNA-binding proteins (Vinson et al., 1989). The C/EBPβ protein regulates many genes 
involved in different cell processes including metabolism, hematopoiesis, adipogenesis, 
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the immune response, and morphogenesis (Poli, 1998; Ramji and Foka, 2002). 
Recently, it has been shown that C/EBPβ mRNA is expressed in the central nervous 
system of adult mice (Nadeau et al., 2005; Sterneck and Johnson, 1998), as well as in 
mouse cortical astrocytes and in hippocampal neurons in vitro (Cardinaux and 
Magistretti, 1996; Yano et al., 1996; Yukawa et al., 1998). Several studies, including 
those from our laboratory, have suggested that this protein may have important 
functions in the brain. It has been shown that C/EBPβ plays an important role in the 
consolidation of long-term memory, suggesting a very important role for this protein in 
the hippocampus (Alberini et al., 1994; Taubenfeld et al., 2001), and Menard et al have 
defined a MEK-C/EBP pathway as being essential for the differentiation of cortical 
progenitor cells into postmitotic neurons (Menard et al., 2002). We have demonstrated 
that C/EBPβ serves as a critical factor in neuronal differentiation (Cortes-Canteli et al., 
2002). In addition, using microarray analysis in neuronal cells overexpressing C/EBPβ, 
we have found that this protein induces the expression of several genes involved in 
inflammatory processes and brain injury (Cortes-Canteli et al., 2004).  
 
Given the limited understanding of C/EBPβ involvement in brain injury and our prior 
speculation that this transcription factor may play a role in this process, we sought to 
address the function of C/EBPβ in cells of the central nervous system in response to a 
brain insult in vitro and in vivo. Our results reveal an strong induction of C/EBPβ in the 
hippocampus of wild type mice following KA injection. Notably, there was a 
pronounced reduction in glial activation and neuronal damage in C/EBPβ knockout 
mice. These data point to a key role for C/EBPβ in excitotoxic brain injury.  
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Results 
C/EBPβ induction in glial primary cultures from C/EBPβ +/+ mice. We have 
previously demonstrated that cell lines stably transfected with C/EBPβ exhibited an 
increase in the expression of many genes involved in inflammation and brain injury 
(Cortes-Canteli et al., 2004). In addition, we have shown that when these cells were 
subjected to injury using an in vitro “scratch-wound” model, the expression of C/EBPβ 
was also up-regulated. These observations have prompted us to investigate whether the 
expression of the endogenous C/EBPβ gene in primary cultures of glia could be 
regulated after neural injury. In order to address this question we first investigated the 
expression of C/EBPβ in glial cultures from C/EBPβ+/+ mice, in response to different 
agents known to cause neural damage through different mechanisms. The C/EBPβ 
signal in these experiments was significantly induced by lipopolysaccharide (LPS), the 
kinase inhibitor staurosporine, KA and glutamate. As shown in Fig. 1A, C/EBPβ basal 
expression levels, measured by Western blot analysis, were low, both in microglial and 
astrocyte primary cultures prepared from wild type mice. However, an increase in 
C/EBPβ was detected after treatment of microglial cells with either LPS or KA (2.3- 
and 1.5-fold, respectively, compared to non-treated cultures). Addition of LPS or 
staurosporine to astrocytes also potently induced C/EBPβ expression (4.2- and 2.2-fold, 
respectively, compared to non-treated cultures), and a lower increase was observed with 
KA (1.7-fold) or glutamate (1.3-fold). At the subcellular level (see confocal images 
shown in Fig. 1B,C) the increase in C/EBPβ protein expression was localized to the 
nucleus in both microglia and astrocytes. KA and glutamate-treated astrocyte cultures 
(Fig. 1B) also showed an increase in C/EBPβ protein in the nucleus, although the 
induction was lower than the one observed following LPS or staurosporine treatment. 
No C/EBPβ signal was detected in astrocytes and microglial cultures from C/EBPβ -/- 
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mice after LPS treatment, confirming the specificity of the antibody used (Fig. 1D,E). A 
similar increase in C/EBPβ levels was also observed in rat primary cultures after 
treatment with LPS or staurosporine (see Supplementary Fig. S1). 
 
Less pro-inflammatory protein induction in C/EBPβ -/- primary microglial 
cultures. To further evaluate the possible role of C/EBPβ in the inflammatory response 
in neural tissues, we next performed in vitro experiments with primary cultures of glial 
cells from C/EBPβ knockout and wild type mice. We tested the capacity of C/EBPβ -
deficient microglial cells to express genes involved in the inflammatory response after 
stimulation with LPS and KA. The Western blots displayed in Fig. 2A show that, in 
contrast to control cells, C/EBPβ-deficient microglia failed to induce the expression of 
Interleukin-1β (IL-1β) in response to LPS and KA. The expression levels of the pro-
inflammatory enzyme cyclooxygenase type-2 (COX-2) were also slightly reduced in 
protein lysates from C/EBPβ -/- microglial cultures. These data were further confirmed 
by confocal analysis. As shown in Fig. 2, the number of microglial cells expressing IL-
1β (Fig. 2B) or COX-2 (Fig. 2C) was reduced in cultures established from C/EBPβ-
deficient animals. Quantification of both western blot and immunocytochemistry 
analysis revealed that IL-1β expression was significantly reduced (~50%) in C/EBPβ-
deficient microglial cultures after treatment with both LPS and KA. A decrease in 
COX-2 levels (~15%) was also observed, although in this case the reduction was not 
statistically significant. Together, these data suggested that C/EBPβ helps to modulate 
the induction of proinflammatory mediators in microglial cells.  
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To ascertain a possible colocalization of IL-1β and COX-2 with C/EBPβ, a multiple 
labeling approach was performed. As depicted by Fig. 2B and C, both IL-1β and COX-
2 colocalized with C/EBPβ in the majority of microglial cells established from wild 
type animals. These data provide evidence that the up-regulation of the gene encoding 
C/EBPβ triggered by LPS or KA takes place essentially within the same cells where 
induction of pro-inflammatory agents is observed. 
 
The expression level of C/EBPβ protein increases in the hippocampus with 
excitotoxic injury. We next investigated the in vivo role of C/EBPβ in a well-
established model of excitotoxic brain injury. Adult mice received intrahippocampal 
injections of either vehicle or KA and, at different times post-injection, the animals 
were perfused and brain tissue was prepared for immunohistochemical analyses. These 
studies revealed that the injection of KA noticeably increased the expression of C/EBPβ 
on the ipsilateral side of the hippocampus of wild type mice when compared to vehicle-
injected controls at 24 hours and 72 hours after surgery (Fig. 3A). Activation was noted 
mainly in the dentate gyrus and, as anticipated, was completely absent in C/EBPβ-
deficient mice (Fig. 3C), a finding that underscores the utility of the A16 antibody for 
the in vivo immunohistochemical studies. In the KA-injected animals occasional 
C/EBPβ-positive cells were also detected within the CA1 and CA3 subfields (data not 
shown), and in the stratum radiatum. In order to identify the cell type-specificity of 
C/EBPβ activation, we next performed a double-labeling analysis using Neurotrace, 
anti-glial fibrillary acidic protein (GFAP), and tomato lectin to identify neurons, 
astrocytes, and microglia, respectively. C/EBPβ immunoreactivity was detected in the 
nuclei of granule neurons of the dentate gyrus as well as in glial cells 24 h after KA 
injection (Fig. 3B). This increase was more pronounced 72 hours post-injection in 
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granule neurons whilst at this time a lower percentage of C/EBPβ-active cells in the 
hippocampus of KA-treated animals were positive for GFAP or tomato lectin.  
 
C/EBPβ-deficient mice are less vulnerable to glial activation. One of the events that 
takes place in the hippocampus following excitotoxic injury is the sequential activation 
of microglia and astroglia. Astrocytes and microglial cells are considered to be key 
players in the induction of the neuronal damage following excitotoxic injury. Analysis 
of hippocampal sections revealed that C/EBPβ -/- mice exhibited reduced astrocytic 
activation and astrogliosis (Fig. 4A). Twenty-four hours following KA injection, wild 
type mice displayed the expected accumulation of GFAP-positive astrocytes (Fig. 4A), 
relative to vehicle-injected animals. At 72 hours, there was an increase in both the 
number and intensity of GFAP-expressing cells. The increase in GFAP 
immunoreactivity was mainly detected in the hilus and the molecular layers surrounding 
the dentate gyrus of the hippocampus. In contrast, the C/EBPβ -/- animals displayed very 
little staining for GFAP, indicating a reduced astroglial response to KA-induced injury. 
Quantification of the data revealed a 30% decrease in the number of GFAP+ cells, both 
the hilus and the molecular layer of the hippocampus of C/EBPβ-/- mice, compared with 
C/EBPβ+/+ animals, seventy two hours after KA injection (Fig 4C). In addition, the 
evaluation of CD11b staining for microglial infiltration revealed a considerably larger 
response in C/EBPβ +/+ animals than in their C/EBPβ -/- counterparts (Fig. 4B). 
Significantly lower levels of CD11b signal were detected in the hippocampus of 
C/EBPβ -/- animals 24 hours after KA injection (Fig 4D). Although the number of 
CD11b+ cells was not statistically different between both groups of animals at 72 hours, 
C/EBPβ +/+ mice exhibited a strong microglial activation as evidenced by 
morphological changes in these cells, which included swelling of the cell somas as well 
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as a thickening and retraction of the cell processes (see insets in Fig. 4B), features 
characteristic of reactive microglia. In contrast, the number of activated microglial cells 
in C/EBPβ -/- mice at this time was significantly lower than that found in their 
C/EBPβ+/+ littermates (data not shown). The CD11b+ cells observed in Fig. 4B can also 
represent infiltrated macrophages, since it is well known that brain injury promotes the 
extravasation of these cells towards the sites of brain injury. In this regard, it has been 
shown that C/EBPβ plays an important role in macrophage activation, as their function 
is severely compromised in C/EBPβ -/- mice (Screpanti et al., 1995). 
 
Impaired pro-inflammatory protein induction in C/EBPβ-deficient mice. We also 
evaluated the production of the cytokine IL-1β, which is secreted by glia in response to 
KA administration and known to enhance neuronal death. IL-1β was elevated in the 
hippocampus of C/EBPβ +/+ mice 72 hours after injection (Fig. 5A), although a slight 
increase was also detected at 24 hours (data not shown). In the C/EBPβ -/- mice, no up-
regulation of IL-1β was observed, consistent with a lack of glial activation. These 
results are in agreement with those obtained in primary cultures of C/EBPβ -/- microglial 
cells (Fig. 2A,B) where a reduced induction of IL-1β in response to LPS and KA 
treatment was observed. The IL-1β+ cells also express the astroglial marker GFAP in 
both the hilus and the molecular layers of the dentate gyrus (Fig. 5B). We also found a 
small number of cells that expressed IL-1β and also bound to the tomato lectin (Fig. 
5B). We did not identify any cells that coexpressed IL-1β and the neuronal marker 
Neurotrace.  
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In addition, we also studied the accumulation of the inducible COX-2 enzyme. 
Overexpression of COX-2 in neural cells appears central to many neuroinflammatory 
conditions. As shown in Fig. 5C, the protein levels of COX-2 were clearly increased in 
the hippocampus at both 24 and 72 hours following KA injection of C/EBPβ +/+ 
animals, relative to vehicle-injected controls (not shown). COX-2 staining was mainly 
observed in the granule cells of the dentate gyrus, although some scattered cells were 
also detected in the stratum radiatum. A small increase in COX-2 levels was also 
observed in some of the KA-treated C/EBPβ -/- animals (mainly at 24 hours), but not as 
robustly or as persistently as that seen in the C/EBPβ +/+ mice. Using a double-labeling 
analysis we found that all COX-2-positive cells in wild-type animals were indeed 
neurons (Fig. 5D). In these cells, the intracellular distribution of the immunoreactivity 
was predominantly perinuclear, which is consistent with the known subcellular 
localization of this enzyme (Nogawa et al., 1997). COX-2 did not appear to colocalize 
with the microglial marker tomato lectin or with the astrocytic marker GFAP (data not 
shown).  
 
Next, we analyzed the expression of 24p3/LCN2 and histidine decarboxylase, two genes 
up-regulated by C/EBPβ (Cortes-Canteli et al., 2004) and probably implicated in 
inflammation and brain injury. Fig. 6 shows that the protein levels of both 24p3 and 
histidine decarboxylase were increase 24 hours after treatment with KA and that this 
increase, as previously observed for IL-1β and COX-2, was markedly reduced in the 
hippocampus of C/EBPβ -/- animals.  
 
C/EBPβ-deficient mice are resistant to excitotoxin-mediated neuronal 
degeneration. In order to better understand the role of C/EBPβ in vivo, we examined 
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the sensitivity of mice lacking C/EBPβ to KA-induced neurodegeneration. To determine 
whether C/EBPβ expression was associated with CA1 and CA3 pyramidal cell death 
after excitotoxicity, hippocampal sections were stained with Fluoro-Jade B (Schmued et 
al., 1997) in order to detect degenerating neurons or NeuN to detect surviving neurons. 
The C/EBPβ -/- mice exhibited significantly less damage in the CA1 and CA3 regions at 
both 24 and 72 hours post-injection, relative to their littermate controls. In contrast, 
C/EBPβ +/+ mice displayed stronger Fluoro-Jade B fluorescence in both the CA1 and 
CA3 subfields of the hippocampus 24 (4.6- and 5-fold, respectively) and 72 (3- and 4.5-
fold, respectively) hours after KA injection, compared with the moderate damage 
observed in C/EBPβ -/- animals (Fig. 7A,C). The apparent resistance to injury in 
C/EBPβ -/- mice was also supported by the higher percentage of healthy cells shown by 
NeuN staining (Fig. 7B). Quantitative studies showed an increase of 6.5- and 3.0-fold in 
the number of neurons in the CA1 and CA3, respectively, subfields of the hippocampus 
in C/EBPβ -/- mice, compared to control C/EBPβ +/+ littermates, 72 hours after KA 
injection (Fig 7D). 
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Discussion 
In the present study we have shown that mice lacking C/EBPβ are less susceptible to 
glial activation and neuronal damage following KA exposure. These results clearly 
establish C/EBPβ as a factor required for the development of excitotoxic brain injury. 
Excitotoxic brain damage is considered one of the major mechanisms by which neurons 
die in the adult central nervous system and it contributes to the pathogenesis of many 
central nervous system disorders, including neurodegenerative disease, brain ischemia, 
epilepsy, and trauma (Coyle and Puttfarcken, 1993; Guo et al., 1999; Hossmann, 1994; 
Lynch and Dawson, 1994). Therefore, our results suggest that C/EBPβ should be 
considered as a possible therapeutic target in brain injury and neurodegenerative 
disorders where excitotoxic neuronal cell death and inflammation processes are 
involved. 
 
The first clues suggesting a possible role for C/EBPβ in brain injury stemmed from in 
vitro studies showing increased activity of this transcription factor during the induction 
of inflammation and damage in neural cells. The expression of C/EBPβ has been 
previously shown to be induced by pro-inflammatory cytokines in primary cultures of 
murine astrocytes (Cardinaux et al., 2000) and by mechanical injury in neuroblastoma 
cells (Cortes-Canteli et al., 2004). In addition, we have demonstrated that 
overexpression of C/EBPβ induces terminal differentiation and cell death in 
neuroblastoma N2A cells (Cortes-Canteli et al., 2002) and also up-regulates the 
expression of genes previously suggested to be involved in brain injury and 
inflammatory processes (Cortes-Canteli et al., 2004). The in vitro studies presented here 
show that LPS, staurosporine, KA and glutamate are each capable of increasing the 
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expression of C/EBPβ in primary cultures of murine glial cells. These findings are 
consistent with previous studies indicating that C/EBPβ is induced in primary cultures 
of glial cells under inflammatory conditions (Cardinaux et al., 2000; Chen et al., 2004; 
Jana et al., 2005) or after glutamate treatment (Yano et al., 1996). Importantly, we have 
shown here that the activation of IL-1β is markedly reduced in glial cultures from 
C/EBPβ -/- mice, suggesting that the expression of this gene could be regulated by 
C/EBPβ. In this context, C/EBPβ has been previously shown to regulate expression of 
inflammatory mediators and pro-inflammatory cytokines, including IL-1β and COX-2, 
in different tissues (Gorgoni et al., 2001; Yang et al., 2000), and C/EBPβ response 
elements have been described in the IL-1β and COX-2 genes (Wadleigh et al., 2000; 
Yang et al., 2000).  
 
 Excitotoxicity proceeds through a complex signaling pathway that includes the 
participation of numerous signaling molecules. The identification of the genes that are 
activated or repressed in specific responses to brain injury, and understanding how such 
alterations in gene expression affect survival and neuronal function, is a central issue in 
the treatment of neurodegenerative diseases. We have demonstrated that the in vivo 
intrahippocampal injection of KA resulted in a strong induction of C/EBPβ, which was 
detected in the nuclei of granule neurons of the dentate gyrus as well as in a subset of 
hippocampal astrocytes and microglia. These observations are consistent with previous 
findings showing that C/EBPβ mRNA is expressed in neurons throughout the mature 
brain, with high levels in the hippocampus (Sterneck and Johnson, 1998). The observed 
induction is also consistent with previous studies showing that the expression of 
C/EBPβ mRNA is increased in facial motor neurons following axonal injury (Nadeau et 
al., 2005). There is considerable evidence that KA treatment is associated with a 
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significant activation of astrocytes and microglial cells and the increased expression of 
classic pro-inflammatory agents, likely through direct regulation by C/EBPβ (Wadleigh 
et al., 2000; Yang et al., 2000). This hypothesis is supported by our data showing that 
the morphological changes associated with the activation of astrocytes and microglial 
cells, as well as the induction of IL-1β and COX-2, are markedly reduced in C/EBPβ 
null mice following KA injection.  
 
The regulation of pro-inflammatory mediators is generally considered a key mechanism 
in neuronal cell death. The enzyme, COX-2, is involved in the pathogenesis of multiple 
neurological disorders associated with inflammation (Giovannini et al., 2003; Teismann 
et al., 2003) and local increases in COX-2 expression in vivo have been associated with 
inflammation, seizures and ischemia (Nogawa et al., 1997; Strauss et al., 2000). In 
addition, an increase in IL-1β expression has been observed in several types of brain 
injury including excitotoxicity (Rothwell and Luheshi, 2000), where it has been shown 
that exogenous IL-1β enhances chemically induced seizures in rats (Vezzani et al., 
2002). IL-1β has also been implicated in a number of neurodegenerative conditions and 
is generally believed to have neurotoxic actions (Rothwell and Luheshi, 2000). 
Therefore the suppression of both COX-2 and IL-1β expression in neurons and glial 
cells, respectively, in response to tissue injury in C/EBPβ -/- mice may be directly 
responsible for the observed reduction in hippocampal neuronal loss. Consistent with 
this idea, it has been previously shown that the promoter of both genes is directly 
regulated by C/EBPβ (Caivano et al., 2001; Shirakawa et al., 1993; Sirois and Richards, 
1993; Wadleigh et al., 2000; Wu et al., 2005; Yang et al., 2000; Zhang and Rom, 1993). 
The C/EBPβ-deficient animals in this study displayed a dramatic reduction in neuronal 
degeneration in the CA1 and CA3 subfields of the hippocampus (Fig. 7), as well as a 
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less marked disruption of these hippocampal neuronal fields 24 and 72 hours post-
injection. In this regard, it has been previously suggested that C/EBPβ may be involved 
in several models of neurodegenerative disease (Bonin et al., 2004; Colangelo et al., 
2002; Giri et al., 2002; Obrietan and Hoyt, 2004). Taken together, there is an 
accumulating body of evidence that C/EBPβ may play a key role in the response to the 
excitotoxic damage that occurs as a result of brain injury or neurodegeneration.  
 
In support of this concept, we have previously demonstrated that other genes involved 
in brain injury and inflammatory processes are up-regulated by C/EBPβ (Cortes-Canteli 
et al., 2004) in neuronal cells. In this work, we have analyzed two of these genes, 
24p3/LCN2 and histidine decarboxilase, and the results obtained show that the induction 
of both proteins after KA injection was reduced in C/EBPβ -/- mice. The 24p3 gene, 
which is most likely a direct target of C/EBPβ (Cortes-Canteli et al., 2004), codes for a 
lipocalin that modulates the immune and inflammatory responses (Logdberg and 
Wester, 2000), and it is also involved in brain damage. Prior reports have shown that 
lipocalin 24p3 is up-regulated after ischemia (Anwaar et al., 1998; MacManus et al., 
2004) and it has been implicated in the apoptosis that follows an inflammatory response 
(Devireddy et al., 2001). Since this gene is mainly expressed in the granular layer of the 
dentate gyrus (Fig. 6A), the same place where the induction in C/EBPβ takes place, it is 
tempting to speculate that this gene could also be a mediator of the effects of C/EBPβ 
after an excitotoxic insult. The other gene analyzed, histidine decarboxylase, converts 
L-histidine in the neurotransmitter histamine and its expression has been linked to brain 
inflammation processes (Musio et al., 2006). Increased histidine decarboxylase activity 
has been found in the hypothalamus after intracerebroventricular administration of LPS 
(Niimi et al., 1993). Interestingly, histamine has been implicated in the pathogenesis of 
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Parkinson Disease, contributing to the loss of dopaminergic neurons in 6-
hydroxydopamine-lesioned rats (Liu et al., 2007), and increased histamine innervation 
has been described in the substantia nigra of Parkinson Disease patients (Anichtchik et 
al., 2000). Another gene that we found to be up-regulated by C/EBPβ in our microarray 
analysis was ornithine decarboxilase (Cortes-Canteli et al., 2004), an enzyme that plays 
a key role in the polyamine biosynthetic pathway. Intriguingly, it has been shown that 
the inhibition of polyamine synthesis abolished neurodegeneration (Soulet and Rivest, 
2003) and that increased polyamine metabolism is neurotoxic (Porcella et al., 1991). 
These observations collectively suggest that one of the mechanisms by which the loss of 
C/EBPβ in the CNS leads to the attenuation of neuronal injury after excitotoxic damage 
is by inhibiting the induction of C/EBPβ-dependent proinflammatory genes. In this 
regard, Kapadia et al, using a model of transient cerebral ischemia, have recently 
provided evidence for the up-regulation of many of the genes previously identified in 
our studies (Cortes-Canteli et al., 2004), including ornithine decarboxylase and 24p3 
(Kapadia et al., 2006). 
 
In summary, our findings have suggested that C/EBPβ plays a critical role in the 
processes leading to the glial activation and resulting neuronal damage that occurs in 
response to an excitotoxic insult. Accordingly, this transcription factor merits serious 
consideration as a potential therapeutic target for the treatment of brain disorders. 
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Materials and Methods 
Mice. C/EBPβ +/+ and C/EBPβ -/- mice were generated from heterozygous breeding 
pairs, kindly provided by Dr. C.M. Croniger and Dr. R.W. Hanson (Case Western 
Reserve University, Cleveland, Ohio) (Screpanti et al., 1995). Genotypes were 
identified based on genomic PCR with DNA prepared from tail using the REDExtract-
N-AmpTM Tissue PCR kit (XNAT kit, Sigma, St. Louis, MO). All procedures with 
animals were carried out in accordance with the European Communities Council, 
directive 86/609/EEC. Special care was taken to minimize animal suffering. 
 
Primary cell culture and treatment. Rat primary astrocyte and microglial cultures 
were prepared as previously described (Luna-Medina et al., 2005). Mouse primary 
C/EBPβ +/+ and C/EBPβ -/- astrocyte and microglial cultures were prepared as rat 
primary cells with some minor modifications. Each culture was generated from a single 
animal. Cultures were stimulated with LPS (10 µg/ml), staurosporine (50 nM), KA (100 
µM) or glutamate (100 µM) and cells were harvested 24 hours later for evaluation of 
C/EBPβ, IL-1β, and COX-2.  
 
Western blot analysis. Cultured primary cells were collected in ice-cold RIPA buffer 
and equal quantities of total protein were separated by 10% SDS-PAGE. After 
electrophoresis, proteins were transferred to nitrocellulose membranes (Protran, 
Whatman, Dassel, Germany) and blots were probed with the indicated primary 
antibodies, as previously described (Cortes-Canteli et al., 2004). The antibodies used 
were the following: DF77 polyclonal anti-rat C/EBPβ (Cortes-Canteli et al., 2002), 
mouse monoclonal anti-mouse C/EBPβ (clone A16, Abcam, Cambridge, UK), goat 
polyclonal anti-COX-2 (Santa Cruz Biotechnologies, CA), monoclonal anti-IL-1β 
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(clone SILK 6, Serotec, Dusseldorf, Germany), and anti-α-tubulin (Sigma) antibodies. 
Secondary peroxidase-conjugated donkey anti-rabbit, rabbit anti-mouse and donkey 
anti-goat antibodies were from Amersham Biosciences (GE Healthcare, 
Buckinghamshire, England), Jackson Immunoresearch (West Grove, PA) and Santa 
Cruz, respectively. Quantification analysis was performed using the Scion Image 
software. Values in the text are the average of at least three experiments.  
 
Immunocytochemistry. At the end of the treatment period the cultures, grown on glass 
cover-slips in 24-well cell culture plates, were washed with phosphate-buffered-saline 
(PBS) and processed for immunocytochemistry as previously described (Luna-Medina 
et al., 2005). Briefly, cells were fixed for 30 minutes with 4% paraformaldehyde at 
25°C, and permeabilized with 0.5% Triton X-100 for 30 minutes at 37ºC. After 1 hour 
incubation with the corresponding primary antibody, cells were washed with PBS and 
incubated with an Alexa-labeled secondary antibody (Alexa 488, Alexa 546 or Alexa 
647; Molecular Probes; Leiden, The Netherlands) for 45 minutes at 37°C. Subcellular 
localization was determined using a Radiance 2100 confocal microscope (Carl Zeiss, 
Jena), with a 405-blue diode, a 488-Argon laser, a 543-Helio/Neon laser and a 633-red 
diode to excite 4',6-diaminidine-2-phenylindole (DAPI), Alexa 488, 546 and 647, 
respectively. Confocal microscope settings were adjusted to produce the optimum 
signal-to-noise ratio. Fluorescence analysis was performed using LaserPix software 
(Bio-Rad, Hercules, CA). To compare fluorescence signals from different preparations, 
settings were fixed for all samples within the same analysis. The antibodies used were 
the following: DF77 polyclonal anti-rat C/EBPβ (Cortes-Canteli et al., 2002), mouse 
monoclonal anti-mouse C/EBPβ (clone A16, Abcam), polyclonal anti-COX-2 (Cayman, 
Ann Arbour, MI), rabbit polyclonal anti- IL-1β (Abcam), rabbit polyclonal anti-GFAP 
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(Dako, Glostrup, Denmark), mouse monoclonal anti-GFAP (Sigma), mouse monoclonal 
anti-rat CD11b (clone OX-42, Serotec), and rat monoclonal anti-mouse CD11b (clone 
M1/70.15, Serotec). Quantification of IL-1β+ and COX-2+ cells was done using Image J 
program using a pixel size between 20 and ∞.  
 
Intrahippocampal injections. Adult male C/EBPβ +/+ and C/EBPβ -/- mice (n = 5 per 
group) were anaesthetized by intraperitoneal injection of ketamine (60 mg/Kg) and 
medetomidine (0.125 mg/Kg) and positioned in a stereotaxic apparatus (Kopf 
Instruments, CA). Kainic acid (0.25 µg in 2.5 µl PBS) was delivered unilaterally into 
the left hippocampus at a speed of 1 µl/minute using the following coordinates from 
Bregma: posterior -2.0 mm; lateral -1.25 mm and a depth of 1.75 mm, according to the 
atlas of Paxinos and Franklin (Paxinos and Franklin, 2001). Control animals of the same 
age were injected with vehicle. The mice were then housed individually to recover. 
 
Immunohistochemistry. Twenty four or seventy two hours after stereotaxic injection, 
the animals were anaesthetized and perfused transcardially with 4% paraformaldehyde 
solution. The brains were removed, postfixed in the same solution at 4ºC overnight, 
cryoprotected in the paraformaldehyde solution containing 30% sucrose, frozen, and 30 
µm coronal sections were obtained in a cryostat. Free floating sections were processed 
for immunohistochemistry using the diaminobenzidine method or double-
immunofluorescence analysis.  
 
For the diaminobenzidine method, floating sections were immersed for 15 minutes in 
3% H2O2 to inactivate endogenous peroxidase, and then blocked for 2 hours at RT in 
5% normal goat serum (Vector Labs, Burlingame, CA) in PBS, containing 4% bovine 
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serum albumin, 0.1 M lysine and 0.1% Triton X-100. Afterwards, the sections were 
incubated overnight at 4ºC with the following primary antibodies: rat monoclonal anti-
CD11b (Serotec) and rabbit polyclonal antibodies anti-GFAP (Dako), anti-COX-2 
(Cayman), anti-24p3 (Davis et al. 1991) and anti-histidine decarboylase 
(Eurodiagnostica, Arnhem, The Netherlands). After several rinses, sections were 
incubated for 1 hour with the correspondent biotinylated secondary antibody and 
processed following the avidin-biotin protocol (ImmunoPure Ultra-Sensitive ABC 
Peroxidase Staining kit, Pierce, Rockford, IL). Finally, the sections were washed, 
dehydrated, cleared in xylene and mounted with DePeX (Serva, Heidelberg, Germany). 
The slides were examined with a Zeiss Axiophot microscope equipped with an 
Olympus DP-50 digital camera. All the images shown correspond to the ipsilateral site 
of the hippocampus. The extent of microgliosis and astrogliosis was quantified by 
counting the number of CD11b-positive cells in the hilus and the stratum radiatum and 
the number of GFAP-positive cells in the hilus and the molecular layer, respectively, of 
the hippocampus in twenty independent well-defined high-magnification (x630) fields 
per animal using a computer-assisted image analySIS software (Soft Imaging System 
Corp.).  
 
For the COX-2 double-immunofluorescence, the protocol was similar to the one 
described above with some modifications. Briefly, the floating sections were blocked in 
PBS containing 0.25% Triton X-100 and 3% normal goat serum and incubated 
overnight with COX-2 polyclonal antibody (Cayman). Then, Alexa secondary antibody 
was added for 1 hour at RT together with Neurotrace Fluorescent Nissl stain (Molecular 
Probes). Finally, the tissue was mounted with Vectashield (Vector Labs) mounting 
medium with DAPI (Vector Labs) to counterstain nuclei, and the sections were 
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examined as described for immunocytochemistry. The sequential mode was used to 
acquire fluorescence images to avoid any interference from overlapping fluorescence. 
 
For double-immunofluorescences and for the diaminobenzidine method with mouse 
monoclonal antibodies, we used the Mouse on Mouse immunodetection kit (Vector 
Labs) to eliminate background due to endogenous mouse immunoglobulins, following 
the manufacture’s instructions. The monoclonal antibodies used were anti-C/EBPβ 
(clone A16, Abcam), anti-IL-1β (Serotec), and anti-NeuN (Chemicon, Temecula, CA) 
antibodies. For double-immunofluorescence analysis, we used rabbit polyclonal anti-
GFAP antibody to detect astrocytes, Neurotrace Fluorescent Nissl stain (Molecular 
Probes) to identify neurons, and Texas Red labeled Lycopersicon Esculentum (Tomato) 
Lectin (Vector Labs) to identify microglial cells. Neuronal integrity was assessed by 
counting the percentage of NeuN-positive cells in the CA1 and CA3 regions of the 
hippocampus in twenty independent well-defined high-magnification (x630) fields per 
animal, as described above. 
 
Fluoro-Jade staining. To evaluate neuronal degeneration, Fluoro-Jade B staining was 
used (Schmued et al., 1997). Briefly, the sections were mounted on gelatin-coated slides 
and then let them dried at RT. After that, the slides were immersed in 100% alcohol, 
followed by 70% alcohol and distilled water. Then the slides were incubated shaking 
gently for 15 minutes in 0.06% potassium permanganate solution followed by 30 
minutes in dark in the staining solution (0.001% Fluoro-Jade B dye, Chemicon). After 
staining, the sections were rinsed in distilled water, let them dry, immersed in xylene 
and mounted with DePeX (Serva). Images were analyzed by confocal microscope, as 
detailed above. The degree of neuronal degeneration was quantified by counting the 
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number of Fluoro-Jade B-stained neurons in the CA1 and CA3 regions of the 
hippocampus. As described above, at least twenty independent well-defined high-
magnification (x630) fields per animal were analyzed. 
 
Statistical determinations. The data shown are the means±s.e. of at least five different 
animals/group. Statistical comparisons for significance between different groups of 
animals were performed using the Student’s test, with p ≤0.05. 
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Figure legends 
Figure 1. Increased expression of C/EBPβ in mouse glial primary cultures after 
treatment with different stimuli. A, Western blot showing an increase in C/EBPβ 
expression in microglial cells treated with LPS and KA and in astrocytes treated with 
LPS, staurosporine, KA or glutamate for 24 hours. Only a small induction was observed 
in astrocyte cultures after treatment with KA or glutamate. Primary astroglial (B) and 
microglial (C) cultures prepared from C/EBPβ +/+ were treated as in (A) and C/EBPβ 
expression was evaluated by immunofluorescence analysis and confocal microscopy 
using a specific anti-C/EBPβ antibody (clone A16), as described in the Materials and 
Methods. Cultures were also stained with anti-CD11b (clone M1/70.15) and anti-GFAP 
antibodies to detect microglia or astrocytes, respectively. To confirm the specificity of 
the anti-C/EBPβ antibody used, primary microglial (D) and astroglial (E) cultures from 
C/EBPβ-/- mice were treated with LPS for 24 hours and C/EBPβ expression was 
evaluated by immunofluorescence analysis and confocal microscopy.  Representative 
results from 3 experiments are shown. Scale bar, 10 µm. Nuclei were counterstained by 
DAPI (blue).  B, basal; LPS, lipopolysaccharide; St, staurosporine; KA, kainic acid; 
Glu, glutamate. 
 
Figure 2. Induction of pro-inflammatory mediators is attenuated in microglial primary 
cultures from C/EBPβ-deficient mice. A, Western blots showing a reduction in the 
expression of IL-1β and COX-2 expression in C/EBPβ −/− microglial culture after 
treatment with LPS and KA for 24 hours, compared to cultures established from 
C/EBPβ +/+ mice. B, C, Primary microglial cultures prepared from C/EBPβ +/+ and 
C/EBPβ -/- mice were treated as in (A), and the expression of C/EBPβ (green), IL-1β (B, 
blue) and COX-2 (C, blue) was evaluated using immunofluorescent detection and 
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confocal microscopy using specific antibodies, as described in the Materials and 
Methods. The third panels show colocalization of C/EBPβ with IL-1β (B) or COX-2 
(C). Microglial marker CD11b is shown in red. Representative results from 3 
experiments are shown. Scale bar, 10 µm.  B, basal; KA, kainic acid; LPS, 
lipopolysaccharide. 
 
Figure 3. Induction of C/EBPβ expression after KA injection in the adult mouse brain. 
A, Immunohistochemical analyses of coronal brain sections prepared from C/EBPβ +/+ 
mice 24 and 72 hours after kainic acid injection. C/EBPβ protein levels were 
substantially enhanced in the stratum radiatum (SR) and in the granular layer (GL) of 
the dentate gyrus of the hippocampus of C/EBPβ +/+ mice 24 and 72 hours post-
injection, compared with vehicle-injected controls. Images are representative for 
experiments from 5 animals. Scale bar, 25 µm. B, Double immunofluorescent labeling 
and confocal microscopic analyses of C/EBPβ after KA injection in C/EBPβ +/+ mice. 
Double labeling studies were performed with an antibody recognizing C/EBPβ (green) 
and different reagents to detect astrocytes (anti-GFAP), microglia (tomato lectin), and 
neurons (Neurotrace) (red labeling). Complete colocalization (yellow) was found in 
neurons, although 24 and 72 hours after KA injection some astrocytes and microglia can 
be found that express C/EBPβ (arrows). Scale bar, 10 µm C, Immunohistochemical 
analyses of coronal brain sections prepared from C/EBPβ -/- mice 24 and 72 hours after 
KA injection. As expected, C/EBPβ -/- mice did not present any C/EBPβ staining. 
Images are representative for experiments from 5 animals. Scale bar, 25 µm.  
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Figure 4. Deficiency of C/EBPβ ameliorates KA-induced gliosis. C/EBPβ +/+ and 
C/EBPβ-/- adult mice were injected with vehicle (V) or KA and sacrificed 24 and 72 
hours post-injection. Coronal sections (30 µm) were stained with antibodies against 
GFAP (A) and CD11b (B) to detect astrocytes and microglia, respectively. A significant 
decrease in both astrogliosis and microgliosis is observed in C/EBPβ -/- mice. A, A 
substantial gliosis is observed in C/EBPβ +/+ mice after KA-injection, which is 
prevented in C/EBPβ -/- mice B, Immunohistochemical detection using anti-CD11b 
antibodies reveals highly ramified microglia in the hippocampus of KA-treated C/EBPβ 
-/-
 mice. In contrast, in C/EBPβ +/+ mice the activated microglial cells exhibit shorter 
and thicker processes and larger cell bodies. Insets are shown at higher magnification in 
the upper right corner of the images corresponding to C/EBPβ +/+ mice. Quantification 
of the number of reactive astrocytes (C) and microglial cells (D) analyzed in the hilus, 
stratum radiatum or molecular layer of the hippocampus. Values represent the 
mean±s.e. from five different animals and two independent sections/animal. #, p≤ 0.05, 
##, p≤ 0.01 and ###, p≤ 0.001, vehicle vs KA-injected animals. *,p≤ 0.05 and ***,p≤ 
0.001, knockout vs wild type KA-injected animals; SR, stratum radiatum; Hil, hilus, 
ML, molecular layer. Images representative for each group are shown. Scale bars, 25 
µm.  
 
Figure 5. Deficiency of C/EBPβ impairs KA induction of pro-inflammatory mediators. 
C/EBPβ +/+ and C/EBPβ -/- adult mice were injected with KA and sacrificed 24 and 72 
hours post-injection. Coronal sections (30 µm) were stained with antibodies against IL-
1β (A, B) and COX-2 (C, D). Neurotrace was used to identify neurons and anti-GFAP  
and tomato lectin to detect astrocytes and microglia, respectively. IL-1β expression, 
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mainly localized in the hilus (Hil) and the molecular layers (ML) surrounding the 
dentate gyrus, was completely absent in the C/EBPβ -/- mice after KA injection, 
compared to their C/EBPβ+/+ littermates. COX-2 immunoreactivity was mainly detected 
in the stratum radiatum (SR) and the granule cell layer of the dentate gyrus (GL). In 
contrast to controls, COX-2 immunoreactivity was noticeably reduced in the C/EBPβ -/- 
mice. Confocal analysis of IL-1β (B) and COX-2 (D) subcellular localization indicate 
that IL-1β is expressed primarily in glial cells whereas COX-2 immunostaining is 
restricted to neurons. Images are representative for experiments from 5 animals. Scale 
bars represent 25 µm (A, C) and 10 µm (B, D). 
 
Figure 6. Deficiency of C/EBPβ decreases KA-induced expression of 24p3/LCN2 and 
histidine decarboxylase. C/EBPβ +/+ and C/EBPβ -/- adult mice were injected with 
vehicle (V) or KA and sacrificed 24 hours post-injection. Coronal sections (30 µm) 
were stained with antibodies against 24p3 (A) and histidine decarboxylase (B). C/EBPβ 
-/-
 mice exhibited lower levels of 24p3 and histidine decarboxylase after KA injection, 
as compared to littermate controls. Representative results from 3 independent 
experiments are shown. Scale bars, 25 µm. SR, stratum radiatum; GL, granular layer; 
Hil, hilus. 
 
Figure 7. Deficiency of C/EBPβ protects neurons from excitotoxic brain damage. 
C/EBPβ +/+ and C/EBPβ -/- adult mice were injected with KA and sacrificed 24 and 72 
hours post-injection. Coronal sections (30 µm) were stained with Fluoro-Jade B (A) and 
anti-NeuN antibody (B). C/EBPβ -/- mice exhibited low levels of neuronal degeneration, 
as detected by Fluoro-Jade B staining and a diminished loss of neurons in the CA1 and 
 36
CA3 regions, as shown by NeuN staining, when compared to littermate controls. Scale 
bars represent 10 µm (A) and 25 µm (B). C, Quantification of the number of 
degenerating neurons analyzed in the CA1 and CA3 areas of the hippocampus. Values 
represent the mean±s.e. from five different animals and two independent 
sections/animal. D, The extent of neuronal damage in the CA1 and CA3 areas of the 
hippocampus was quantified as described in Materials and Methods. Data were 
normalized against the mean values given by vehicle-injected mice. Values represent 
the mean±s.e. from five different animals and two independent sections/animal. *,p≤ 
0.05; **,p≤ 0.01; ***,p≤ 0.001, versus vehicle-injected animals at each time point. 
 
 
  
 
 
 







